In the BioHarmony Drug Report Database

"Preview" Icon

Olopatadine

Pataday, Patanase, Opatanol (olopatadine) is a small molecule pharmaceutical. Olopatadine was first approved as Pataday on 1996-12-18. It is used to treat allergic conjunctivitis in the USA. It has been approved in Europe to treat allergic conjunctivitis. Olopatadine hydrochloride’s patents are valid until 2032-05-19 (FDA).

 

Trade Name

 

Opatanol
 

Common Name

 

olopatadine
 

ChEMBL ID

 

CHEMBL1189432
 

Indication

 

allergic conjunctivitis
 

Drug Class

 

Tricyclic histaminic-H1 receptor antagonists, loratadine derivatives

Image (chem structure or protein)

Olopatadine structure rendering